海外の治験の状況「前立腺癌」での検索結果
648件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- Radium-223 Dichloride in the treatment of patients diagnosed with prostate cancer that has spread to the bone
- Castrate Resistant Prostate Cancer/Hormone-Refractory Prostate Cancer patients with bone metastasis MedDRA version: 18.1 Level: LLT Classification code 10036916 Term: Prostate cancer stage D System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Austria, Belgium, Canada, Czech Republic, Denmark, Finland, Germany, Ireland, Israel, Italy, Mexico, Netherlands, Norway, Poland, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
- 2012-03-28
Not recruiting
- An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants
- Progressive Metastatic Prostate Cancer
- China, Hong Kong, Korea, Republic of, Taiwan
- 2014-11-13
Not recruiting
- Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate Cancer
- Asian Chemo-naïve Patients With Metastatic Castrate-resistant Prostate Cancer
- China, Korea, Republic of, Taiwan
- 2014-02-06
Not recruiting
- Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone
- Prostatic Neoplasms
- Australia, Brazil, Canada, Chile, Czech Republic, Czechia, Finland, France, Germany, Israel, Italy, Korea, Republic of, Poland, Spain, Sweden, Taiwan, United Kingdom, United States
- 2013-12-24
Not recruiting
- Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.
- Metastatic Castration-resistant Prostate Cancer;Metastatic Castration-resistant Prostate Cancer;Metastatic Castration-resistant Prostate Cancer
- Belgium, Canada, Czech Republic, Czechia, France, Italy, Netherlands, Poland, Russian Federation, Spain, United Kingdom, United States
- 2013-10-24
Not recruiting
- Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases
- Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms
- Finland, Germany, Ireland, Israel, Italy, Norway, Spain, Sweden, United Kingdom, United States
- 2013-08-30
Recruiting
- A Multinational, Phase 3, Randomized, Double Blind, Placebo Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration Resistant Prostate Cancer
- Nonmetastatic Castration-Resistant Prostate Cancer # Prostate Cancer # Cancer of the Prostate;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Italy, Korea, Republic of, Malaysia, Netherlands, New Zealand, Poland, Russian Federation, Serbia, Singapore, Slovakia, Spain, Sweden, Taiwan, Province of China, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2015-06-23
Recruiting
- Hormonal therapy with or without docetaxel in treating patients with high-volume metastatic prostate cancer
- prostate cancer
- China
- 2015-01-06
Recruiting
- DNA-repair defects and Platinum-based chemotherapy in metastatic castration-resistant prostate cancer
- prostate cancer
- China
- 2016-10-23
Recruiting
- Phase II Trial of Pembrolizumab (MK-3475) in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Chemotherapy (KEYNOTE-199)
- Metastatic Castration-resistant Prostate Cancer (mCRPC);C61 - Malignant neoplasm of prostate
- Australia, Canada, Estonia, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, Korea, Republic of, Poland, Spain, Sweden, Switzerland, Taiwan, Province of China, Turkey, United Kingdom, United States
- 2016-10-17